Peregrine Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Peregrine Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-116,043	Closed	-$19.2M	–	352
2021 Q2	$19.2M	Sell	116,043 -6,567	-5%	-$1.1M	0.34%	83
2021 Q1	$18.8M	Sell	122,610 -17,172	-12%	-$2.33M	0.35%	105
2020 Q4	$17.5M	Buy	+139,782	New	+$15.6M	0.33%	109

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Peregrine Capital Management's PRAH Position: Q3 2021 in Review

Peregrine Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 116,043 shares — an estimated $19.2M sold.

Peregrine Capital Management first reported a position in PRAH in Q4 2020 and held it in 3 quarters. The position peaked at $19.2M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Peregrine Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Peregrine Capital Management sold 116,043 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $19.2M.
Peregrine Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2020 and held it in 3 quarters.
Peregrine Capital Management's PRA Health Sciences, Inc. position peaked at $19.2M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Peregrine Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.